ZEMDAP® – S Tablet

ZEMDAP® – S is a fixed-dose oral antidiabetic combining Sitagliptin, a DPP-4 inhibitor, and Dapagliflozin, a selective SGLT2 inhibitor. Together, they offer broad-spectrum glycemic control by lowering fasting and postprandial glucose, with added benefits of weight management, blood pressure reduction, and cardiorenal protection. It’s ideal for patients with type 2 diabetes mellitus not adequately controlled with single-agent therapy or metformin.

Categories: ,

Description

Composition (Each Film-Coated Tablet Contains):

  • Sitagliptin Phosphate – Equivalent to Sitagliptin 100 mg

  • Dapagliflozin – 10 mg

Category: Diabetes Care / SGLT2 + DPP-4 Inhibitor Combination
Form: Oral Tablet
Pack Size: 10×10 Blister / Alu-Alu


Product Description:

ZEMDAP® – S is a fixed-dose oral antidiabetic combining Sitagliptin, a DPP-4 inhibitor, and Dapagliflozin, a selective SGLT2 inhibitor. Together, they offer broad-spectrum glycemic control by lowering fasting and postprandial glucose, with added benefits of weight management, blood pressure reduction, and cardiorenal protection. It’s ideal for patients with type 2 diabetes mellitus not adequately controlled with single-agent therapy or metformin.


Key Benefits:

  • Dual mechanism targets both renal and hormonal glucose regulation

  • Improves HbA1c, fasting, and post-meal sugar levels

  • Lowers body weight and systolic blood pressure

  • Minimal risk of hypoglycemia when used alone

  • Cardiovascular and renal protective effects with long-term use


How it works:

  • Dapagliflozin reduces glucose reabsorption in the kidneys via SGLT2 inhibition, promoting urinary glucose excretion.

  • Sitagliptin increases active incretin (GLP-1 & GIP) levels by inhibiting DPP-4, enhancing insulin release and suppressing glucagon in a glucose-dependent manner.

Together, they provide complementary and sustained glycemic control across the day.


How to use:

  • Take one tablet once daily, preferably in the morning, with or without food, as prescribed by your physician.

  • Swallow whole with water — do not crush or chew.

  • Maintain hydration and monitor blood glucose regularly.

  • Routine follow-ups advised to assess kidney function and overall control.


Safety Advice:

  • May cause mild urinary or genital infections — maintain hygiene and hydration.

  • Low risk of hypoglycemia unless used with insulin or sulfonylureas.

  • Monitor renal function periodically.

  • Do not skip doses; consistent use is important for sustained control.


Precautions:

  • Not recommended in patients with type 1 diabetes or diabetic ketoacidosis (DKA).

  • Caution in patients with renal impairment, recurrent UTIs, or pancreatitis history.

  • Avoid during pregnancy or breastfeeding unless medically advised.

  • Inform your doctor about all other antidiabetic or diuretic medications.


Storage:

Store in a cool, dry place below 25°C. Protect from direct light and moisture.
Keep out of reach of children.

Reviews

There are no reviews yet.

Be the first to review “ZEMDAP® – S Tablet”

Your email address will not be published. Required fields are marked *